Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rpeiro
    Junior Member
    • Oct 2011
    • 4

    #1

    RNA-seq normalization in samples with different cell densities

    Hi all,

    We are going to make an experiment involving D melanogaster samples each of wich include about a 25 % of cells being part of a differentially expressed tissue. We are afraid that changes in genes with low expression levels can be masked due to this low representation of 25 %.
    Does anybody know what is the more accurate normalization method?
    Thank you in advance
  • jparsons
    Member
    • Feb 2012
    • 62

    #2
    I have been working on a method to "unmix" RNA-seq data from mixtures for awhile, and I think it may be of some help to your situation.

    You would need to:
    *Be able to collect a sample of your "unwanted" tissue which was free of contaminants
    *Be able to measure the mass of ribodepleted RNA (this can be done as a part of the sequencing experiment using spike-in RNA or by using more traditional means)
    *Be willing to accept that your uncertainty "about a 25%" will propagate

    If these options are possible for you, we can discuss details.

    Comment

    • rpeiro
      Junior Member
      • Oct 2011
      • 4

      #3
      Thank you for answer me jparsons. Regarding with the points you posted:

      *Be able to collect a sample of your "unwanted" tissue which was free of contaminants

      We planned to sequence WT tissue as a control

      *Be able to measure the mass of ribodepleted RNA (this can be done as a part of the sequencing experiment using spike-in RNA or by using more traditional means)

      The selection of RNA to sequence will be using polyA tails

      *Be willing to accept that your uncertainty "about a 25%" will propagate

      An amount of uncertainty is inherent in this kind of experiments. Lets hope we be able to decrease it.

      Thank you

      Comment

      • jparsons
        Member
        • Feb 2012
        • 62

        #4
        polyA selection is still filtering total RNA into mRNA and must be accounted for.

        It still sounds like you may have an ideal experiment for a mixture design.

        Call your WT tissue A, your modified tissue B, and your experimental samples C.

        Your expression values in C will be: C = (A*.75*mrnaA)+(B*.25*mrnaB)

        You could directly measure the mRNA content qRT-PCR, or determine it using spiked-in RNA. We calculate it as sample reads per microgram of total RNA divided by spike-in reads per microgram of spike-in RNA. This calculation emphasizes that the mRNA fraction is a correction for the differential enrichment between polyadenylated spike-in RNA and total RNA, which is only partly composed of mRNA.

        The ratio of spike reads/sample reads in your mixture sample C is related to your spike/sample reads in samples A+B in the same way, so you can back-calculate the mrnaB from the mrnaC.

        Again, the main limitation here is how well you are able to estimate the proportion of the tissues in your mixture samples. If you have more than 5% error in your proportion estimate(which is where the .75 and .25 come from), this analysis may be worse than the alternative.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...